|
Monday, November 18, 2013
Print Current Session:
 |
|
| SESSION 4 SCHEDULE | |
| 1:30 PM - 1:40 PM | Cross Sectional Imaging Of The Liver: MR, CT Or PET/CT |
| Presenter(s):Rick Patt, MD | |
| View Abstract | |
| 1:40 PM - 1:50 PM | Indications And Contraindications For Liver Transplant |
| Presenter(s):Paul J. Gaglio, MD | |
| View Abstract | |
| 1:50 PM - 2:00 PM | UNOS Criteria: Improving The Chances Of Your Patient Obtaining A Liver |
| Presenter(s):Jonathan M. Schwartz, MD | |
| View Abstract | |
| 2:00 PM - 2:10 PM | Resection vs. Locoregional Therapy For Small HCCs: Are They Equivalent |
| Presenter(s):Laura Crocetti, MD, PhD / Riccardo Lencioni, MD | |
| View Abstract | |
| 2:10 PM - 2:20 PM | DEB TACE With Or Without Sorafenib: How Do We Decide |
| Presenter(s):Jean Francois H. Geschwind, MD | |
| View Abstract | |
| 2:20 PM - 2:30 PM | DEB TACE Should Be The Initial Treatment Of HCC Greater Than 3 cm: Does Particle Size Matter |
| Presenter(s):Sebastian Flacke, MD, PhD | |
| View Abstract | |
| 2:30 PM - 2:40 PM | Radioembolization Should Be The Initial Treatment For HCC Greater Than 3 cm |
| Presenter(s):Renee M. Moadel, MD | |
| View Abstract | |
| 2:40 PM - 2:50 PM | Locoregional Approaches For HCC: An Update On Clinical Trials |
| Presenter(s):Laura Crocetti, MD, PhD / Riccardo Lencioni, MD | |
| 2:50 PM - 3:00 PM | Complications Of Locoregional Therapy: Avoidance And Management |
| Presenter(s):Matthew S. Johnson, MD | |
| View Abstract | |
| 3:00 PM - 3:10 PM | Hypertrophy Of Liver Remnant: Is Arterial Embolization In Conjunction With PVE Better Than PVE Alone In Cirrhotic Patients |
| Presenter(s):David C. Madoff, MD | |
| View Abstract | |
| 3:10 PM - 3:20 PM | Difficult TACE: Technical Pearls For Success |
| Presenter(s):James Caridi, MD | |
| View Abstract | |
| 3:20 PM - 3:30 PM | Use Of Cone Beam CT To Facilitate And Evaluate TACE Procedures |
| Presenter(s):Jacob Cynamon, MD / Yosef Golowa, MD | |
| View Abstract | |
| 3:30 PM - 3:50 PM | Break – Visit Exhibits (South Corridor, 2nd Floor) |
| 3:50 PM - 4:00 PM | Liver Metastasis From Colorectal Carcinoma: An Oncologist's View Of IR Interventions |
| Presenter(s):Nancy Kemeny, MD | |
| View Abstract | |
| 4:00 PM - 4:10 PM | Predicting And Avoiding Complications When Treating Metastatic Disease With Y-90 |
| Presenter(s):Riad Salem, MD, MBA | |
| View Abstract | |
| 4:10 PM - 4:20 PM | Should Antireflux Catheters Be Used More Often For Y-90 Procedures |
| Presenter(s):Aaron M. Fischman, MD | |
| View Abstract | |
| 4:20 PM - 4:30 PM | Vascular Redistribution To Simplify Radioembolization Or Whole Liver Therapy |
| Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
| View Abstract | |
| 4:30 PM - 4:40 PM | Surgical And Percutaneous Experience With Whole Liver Chemoperfusion |
| Presenter(s):Milan Kinkhabwala, MD / Steven K. Libutti, MD | |
| View Abstract | |
| 4:40 PM - 4:50 AM | Percutaneous Management Of Neuroendocrine Tumors |
| Presenter(s):Karen T. Brown, MD | |
| View Abstract | |
| 4:50 PM - 5:00 PM | Pancreatic Cancer: Is IRE Safe And Effective |
| Presenter(s):Govindarajan Narayanan, MD | |
| View Abstract | |
| 5:00 PM - 5:20 PM | Discussion |
| END OF SESSION 4 | |
| previous | next |